Your browser doesn't support javascript.
loading
Development and Validation of a UHPLC-MS/MS Method for Quantitation of Almonertinib in Rat Plasma: Application to an in vivo Interaction Study Between Paxlovid and Almonertinib.
Tang, Peng-Fei; Bao, Su-Su; Gao, Nan-Yong; Shao, Chuan-Feng; Xie, Wei-Fei; Wu, Xue-Meng; Zhao, Le-Ping; Xiao, Zhong-Xiang.
Afiliação
  • Tang PF; Affiliated Yueqing Hospital, Wenzhou Medical University, Wenzhou, China.
  • Bao SS; Affiliated Yueqing Hospital, Wenzhou Medical University, Wenzhou, China.
  • Gao NY; Department of Pharmacology, School of Pharmacy of Wenzhou Medical University, Wenzhou, China.
  • Shao CF; Affiliated Yueqing Hospital, Wenzhou Medical University, Wenzhou, China.
  • Xie WF; Affiliated Yueqing Hospital, Wenzhou Medical University, Wenzhou, China.
  • Wu XM; Market Supervision Administration of Yueqing City, Wenzhou, China.
  • Zhao LP; Affiliated Yueqing Hospital, Wenzhou Medical University, Wenzhou, China.
  • Xiao ZX; Affiliated Yueqing Hospital, Wenzhou Medical University, Wenzhou, China.
Front Pharmacol ; 13: 960311, 2022.
Article em En | MEDLINE | ID: mdl-35935882

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article